Recent Quotes

My Watchlist

Indicators

Overview

News

Currencies

International

Treasuries

NanoViricides, Inc. Common Stock (NY:NNVC)

1.320 -0.090 (-6.38%)

Official Closing Price Updated: 8:00 PM EDT, May 9, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	119,474
Open	1.440
Bid (Size)	1.300 (5)
Ask (Size)	1.350 (1)
Prev. Close	1.410
Today's Range	1.280 - 1.440
52wk Range	0.9400 - 3.590
Shares Outstanding	15,641,611
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Clears Ethics Review for Phase II Mpox Trial in DRC

May 08, 2025

Via Investor Brand Network

Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo

May 08, 2025

Via ACCESS Newswire

Performance

YTD	-7.0%	-7.0%
1 Month	+20.0%	+20.0%
3 Month	+12.8%	+12.8%
6 Month	-8.3%	-8.3%
1 Year	-27.9%	-27.9%

More News

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) to Present at D. Boral Capital Inaugural Global Conference

May 05, 2025

Via Investor Brand Network

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances Measles Drug Development with Broad-Spectrum Antiviral NV-387

April 29, 2025

Via Investor Brand Network

NanoViricides, Inc. Has Filed its Quarterly Report

February 19, 2025

Via ACCESS Newswire

Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals

January 08, 2025

Via ACCESSWIRE

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It

April 29, 2025

Via ACCESS Newswire

Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak

April 14, 2025

Via ACCESS Newswire

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights Antiviral Pipeline, Positions Stock as Market Hedge

March 11, 2025

Via Investor Brand Network

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

March 11, 2025

Via ACCESS Newswire

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak

March 04, 2025

Via Investor Brand Network

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

March 04, 2025

Via ACCESS Newswire

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials

February 19, 2025

Via Investor Brand Network

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Claims NV-387 Ready to Combat Bird Flu

February 11, 2025

Via Investor Brand Network

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

February 11, 2025

Via ACCESS Newswire

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Showcases NV-387’s Broad-Spectrum Antiviral Potential at MicroCap Conference

January 29, 2025

Via Investor Brand Network

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

January 29, 2025

Via ACCESS Newswire

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Partners with CRO to Advance NV-387 Antiviral Drug to Phase II Trials

January 27, 2025

Via Investor Brand Network

NanoViricides Engages CRO for Phase II Clinical Trial

January 27, 2025

Via ACCESS Newswire

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present Broad-Spectrum Antiviral Innovations at Biotech Showcase 2025

January 13, 2025

Via Investor Brand Network

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

January 13, 2025

Via ACCESSWIRE

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Highlights NV-387 as a Broad-Spectrum Antiviral Solution to Emerging Threats

January 08, 2025

Via Investor Brand Network

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Touts NV-387 as Key Defense Against Potential Bird Flu Pandemic

December 23, 2024

Via Investor Brand Network

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

December 23, 2024

Via ACCESSWIRE

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

November 27, 2024

Via ACCESSWIRE

Frequently Asked Questions

Is NanoViricides, Inc. Common Stock publicly traded?

Yes, NanoViricides, Inc. Common Stock is publicly traded.

What exchange does NanoViricides, Inc. Common Stock trade on?

NanoViricides, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for NanoViricides, Inc. Common Stock?

The ticker symbol for NanoViricides, Inc. Common Stock is NNVC on the New York Stock Exchange

What is the current price of NanoViricides, Inc. Common Stock?

The current price of NanoViricides, Inc. Common Stock is 1.320

When was NanoViricides, Inc. Common Stock last traded?

The last trade of NanoViricides, Inc. Common Stock was at 05/09/25 08:00 PM ET

What is the market capitalization of NanoViricides, Inc. Common Stock?

The market capitalization of NanoViricides, Inc. Common Stock is 20.65M

How many shares of NanoViricides, Inc. Common Stock are outstanding?

NanoViricides, Inc. Common Stock has 21M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.